MAS1 and hypertensive disorder: Our results showed that aliskiren administration increased ACE2 and MAS protein levels in female kidneys exposed to maternal HF intake, which implies that the protective effect of aliskiren in hypertension programmed by maternal HF intake in females is related to the activation of ACE2-Ang-(1–7)-MAS pathway.